Home › Research › Risk factors
The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias
Grace C. George, Sarah A. Keller, Erin L. Abner, Sara Dubowsky Adar, Michael Louis Alosco, Liana G. Apostolova, Kelly M. Bakulski, Lisa Laverne Barnes et al.. Alzheimer s & Dementia, 2025-11-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
We highlight a general overview and methodology of TNS. Data collection is ongoing; however, preliminary findings indicate that the adverse social exposome is related to ADRD biomarkers, neuropathology, and cognitive function. TNS is the largest study of adverse social exposome and ADRD, using the ADRC network to build robust scientific consortia. Its findings will inform ADRD interventions, precision medicine, and policy. HIGHLIGHTS: The Neighborhoods Study (TNS) investigates adverse social exposome and brain health. TNS is a collaboration among 22 Alzheimer's Disease Research Centers. TNS will give insight on environmental and exposomal factors which may be modifiable. Participant lifetime addresses are linked to temporal adverse social exposome metrics. This study's findings will inform precision approaches to mitigate dementia risk.
What this study adds
Evidence grade: Low
This paper describes the methodology of an ongoing study and reports only preliminary findings that adverse social exposome is related to ADRD biomarkers, neuropathology, and cognitive function. Because data collection is ongoing, no conclusions can yet be drawn about treating, curing, or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
George, G. C., Keller, S. A., Abner, E. L., Adar, S. D., Alosco, M. L., Apostolova, L. G., et al. (2025). The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70810
Vancouver
George GC, Keller SA, Abner EL, Adar SD, Alosco ML, Apostolova LG, et al. The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70810. PMID: 41230793.
BibTeX
@article{george2025-41230793,
author = {George, Grace C. and Keller, Sarah A. and Abner, Erin L. and Adar, Sara Dubowsky and Alosco, Michael Louis and Apostolova, Liana G. and Bakulski, Kelly M. and Barnes, Lisa Laverne and others},
title = {{The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementias}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70810},
pmid = {41230793},
url = {https://doi.org/10.1002/alz.70810}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We highlight a general overview and methodology of TNS.
- Data collection is ongoing; however, preliminary findings indicate that the adverse social exposome is related to ADRD biomarkers, neuropathology, and cognitive function.
- TNS is the largest study of adverse social exposome and ADRD, using the ADRC network to build robust scientific consortia.
- Its findings will inform ADRD interventions, precision medicine, and policy.
- HIGHLIGHTS: The Neighborhoods Study (TNS) investigates adverse social exposome and brain health.
Why it matters
This paper describes the methodology of an ongoing study and reports only preliminary findings that adverse social exposome is related to ADRD biomarkers, neuropathology, and cognitive function. Because data collection is ongoing, no conclusions can yet be drawn about treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Amy Kind: h-index 47 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Stanford University: institution h-index 2,684 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 31 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41230793) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk factors from nearby years
Also in Risk factors
395 studies in the library are filed under Risk factors with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk factors hub.